Clinical Trial Update: Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of celecoxib on restenosis after coronary intervention and the evolution of atherosclerosis. The sponsor is Seou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Coronary Restenosis

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Angioplasty, Transluminal, Percutaneous Coronary, Coronary Restenosis | Phase 4 | Status: UNKNOWN